Pharmacy intern provisions modified.
HF2997 modifies Minnesota’s pharmacy intern laws and related fee and training provisions. The bill expands the statutory definition of “pharmacist intern” to include participants in residency or fellowship programs who are not licensed in Minnesota, as well as certain foreign pharmacy graduates seeking internship experience. It also updates the intern registration and renewal framework, including annual renewal timing, late fees, lapse/reinstatement rules, and conditions for maintaining active intern status.
The bill lowers the pharmacy intern application fee from $75 to $25 and sets the annual renewal fee at $25 beginning January 1, 2026. It also creates a transition rule for individuals who paid the higher fee between May 1, 2024, and June 30, 2025, exempting them from the new renewal fee for their first two renewal cycles. In addition, the bill clarifies that an intern registration ends when the person is no longer enrolled in an ACPE-accredited pharmacy program, and it allows the Board of Pharmacy to extend certain late applications by one year and prorate fees in limited circumstances.
HF2997 also revises the internship credit-hour requirements for pharmacist licensure. It maintains the 1,600-hour internship requirement but specifies limits on how those hours may be earned, including caps on first-year structured experience, concurrent internship time, and weekly hours earned across multiple sites. The bill repeals outdated Minnesota Rules provisions that previously defined pharmacist interns and described internship competencies and evidence of completion, replacing them with updated statutory language.
The bill’s impact is primarily on the Board of Pharmacy, pharmacy students, interns, residency and fellowship participants, foreign pharmacy graduates, and employers or preceptors involved in internship training. It reduces fees for intern registration, modernizes eligibility categories, and shifts more of the internship framework from administrative rule to statute. It also standardizes renewal and reinstatement procedures and may make it easier for certain nontraditional pharmacy trainees to qualify for Minnesota intern registration.
The overall sentiment appears neutral to favorable based on the bill text and lack of recorded opposition in the provided materials. The measure reads as a technical and administrative update intended to streamline pharmacy intern regulation and reduce costs for applicants. No committee testimony or votes were provided, so there is no documented controversy in the available record. The main potential point of contention would likely be the policy choice to broaden intern eligibility and change fee structures, but no specific objections are shown here.
The bill amends Minnesota Statutes sections 151.01, 151.065, and 151.101 to change who qualifies as a pharmacy intern, how intern registrations are renewed and reinstated, and what fees apply. It also repeals certain Minnesota Rules provisions governing intern definitions, training competencies, and proof of internship completion, thereby moving those subjects into statute and updating the Board of Pharmacy’s regulatory framework.
The available record suggests a generally neutral-to-positive reception. The bill appears to be a technical modernization of pharmacy intern rules, with fee reductions and clearer pathways for residency, fellowship, and foreign pharmacy graduates. No committee debate, recorded votes, or opposition statements were provided, so there is no evidence of significant controversy in the materials supplied.
No specific points of contention are documented in the provided committee or voting history. Potential areas of policy debate, based on the text alone, could include the expansion of intern eligibility to residency/fellowship participants and foreign pharmacy graduates, the reduction in intern fees, and the shift from rule-based to statutory internship requirements. However, no named opponents or supporters are identified in the available record.